ArticleJournal of surgical case reports2026
Primary anorectal malignant melanoma with synchronous hepatic metastases in middle-aged patient: a case report.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anorectal malignant melanoma is a rare, notably aggressive malignancy, comprising fewer than 1% of all melanoma cases. Its early symptoms frequently resemble benign anorectal conditions, which may lead to diagnostic delays and poor outcomes. We report a case of a 42-year-old, previously healthy male who presented with a two-month history of progressive constipation, unintentional weight loss, and lower abdominal discomfort associated with melena. Imaging revealed a mass extending from the anal canal into the distal rectum, with hepatic metastases. Histopathological examination confirmed malignant melanoma with positive immunohistochemical staining for HMB-45 and Melan-A, and negative S-100. A diverting functional colostomy was performed for impending obstruction, and first-line nivolumab was initiated, but the patient deteriorated rapidly and died on best supportive care. This case highlights the silent nature of this malignancy and the importance of considering rare yet aggressive tumors when dealing with atypical or unexplained anorectal lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.